Immunity is one of the fastest growing—and most elusive—nutraceutical markets. The fear of losing one’s job if they become ill, global mega viruses, e.g., H1N1, an unprecedented intolerance among schools to allow children with even minor ailments to stay in class, and the return of serious infectious diseases, e.g., whooping cough, have heated up the immunity market, way beyond its upcoming seasonal boost.
10.01.10